Virchows Archiv

, Volume 425, Issue 3, pp 237–241 | Cite as

Metastatic potential of small and minimally invasive breast carcinomas

  • H. P. Sinn
  • A. Oelmann
  • H. W. Anton
  • I. J. Diel
Original Article

Abstract

Invasive ductal mammary carcinomas (IDC) of 1 cm in tumour size or less account for less than 20% of all IDC. We have observed 167 such cases at our Institution between 1985 and 1989. These were divided into carcinomas with an extensive or predominant intraductal component (EIC or PIC, being least 2× or 4× larger than the invasive component; 90) and compared statistically with the control group (no EIC or PIC; 77) for known prognostic factors and for their metastatic behaviour. Lymph nodes were step sectioned in order to detect occult micrometastases. The median follow up time was 62.6 months. Lymph node metastases were seen in 10% of pT1a and 19% of pT1b cases. Significant differences were found when comparing the EIC/PIC group with the control group (pT1a: 11% vs. 0%, pT1b: 37% vs. 11% lymph node metastases). Also, axillary and infraclavicular recurrence rates were higher for EIC/PIC carcinomas compared with other IDC of ≤1 cm (9.3% vs. 4.2%). This significantly adverse metastatic behaviour of the EIC/PIC tumours may be in part due to the more frequent occurrence of multifocal tumours in this group (in 43% vs. 6%), resulting in a greater tumour burden. We conclude that the overall risk of lymph node metastasis is not negligible in carcinomas of 1 cm or less in diameter with the risk being more than doubled for carcinomas with an intraductal component exceeding the invasive tumour by a factor of two. These differences were relevant only to regional metastases; the risk for distant metastasis and survival was identical after 5 years.

Key words

Breast cancer Lymph node metastasis TNM classification Intraductal component 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bartelink H, Borger JH, van Dongen JA, Peterse JL (1988) The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol 11:297–303Google Scholar
  2. 2.
    Bässler R, Böcker W, Hermanek P, Pickartz H, Prechtel K, Schauer A, Schnurch HG, Stegner HE (1992) Die gegenwärtige Situation des Gradings beim Mammakarzinom. Pathologe 13:130–134Google Scholar
  3. 3.
    Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C, Asselain B (1992) Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet 339:1245–1248Google Scholar
  4. 4.
    Eberlein TJ, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris JR (1990) Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg 125:771–775Google Scholar
  5. 5.
    Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, Schnitt SJ, Silver B, Boyages J, Harris JR (1990) The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113–118Google Scholar
  6. 6.
    Kinne DW (1990) Surgical management of stage I and stage II breast cancer. Cancer 66:1373–1377Google Scholar
  7. 7.
    Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Roth J, Spitalier JM (1990) Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65:1867–1878Google Scholar
  8. 8.
    Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Spitalier JM (1990) Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591–598Google Scholar
  9. 9.
    Leopold KA, Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, Harris JR (1989) Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 16:11–16Google Scholar
  10. 10.
    Osteen RT, Connolly JL, Recht A, Silver B, Schnitt SJ, Harris JR (1987) Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg 122:1248–1252Google Scholar
  11. 11.
    Page DL, Anderson TJ, Rogers LW (1987) Carcinoma in situ (CIS). In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, New York, pp. 157–192Google Scholar
  12. 12.
    Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, Harris JR (1988) The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14:3–10Google Scholar
  13. 13.
    Rosner D, Lane WW, Penetrante R (1991) Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 67:1498–1503Google Scholar
  14. 14.
    Schnitt SJ, Connolly JL, Khettry U, Mazoujian G, Brenner M, Silver B, Recht A, Beadle G, Harris JR (1987) Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 59:675–681Google Scholar
  15. 15.
    Solin LJ, Fowble B, Schultz DJ, Goodman RL (1989) Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 16:373–381Google Scholar
  16. 16.
    Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL (1992) Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961–968Google Scholar
  17. 17.
    UICC (1992) TNM classification of malignant tumours. Springer, Berlin Heidelberg New YorkGoogle Scholar
  18. 18.
    van Dongen JA, Fentiman IS, Harris JR, Holland R, Peterse JL, Salvadori B, Stewart HJ (1989) In-situ breast cancer: the EORTC consensus meeting. Lancet 2:25–27Google Scholar
  19. 19.
    Veronesi U (1989) Clinical management of minimal breast cancer. Semin Surg Oncol 5:145–150Google Scholar
  20. 20.
    WHO (1981) Histological typing of breast tumors. World Health Organization, GenevaGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • H. P. Sinn
    • 1
  • A. Oelmann
    • 1
  • H. W. Anton
    • 2
  • I. J. Diel
    • 2
  1. 1.Department of PathologyUniversity of HeidelbergHeidelbergGermany
  2. 2.Department of Obstetrics and GynaecologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations